Skip to main content
Clinical Trials/CTRI/2010/091/000082
CTRI/2010/091/000082CompletedPhase 1

A Phase I clinical trial to assess safety of the Influenza Vaccine (whole virion, Inactivated) A/H1N1 (Pandemic) in Adults

Serum Institute of India Limited SII0 sites50 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Completed
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria:
  • 1) Normal healthy subjects of 18-49 years age at the time of screening. 2)Free of obvious health problems.

Exclusion Criteria

  • 1.Have a known allergy to eggs or other components of the vaccine. 2.Pregnancy 3. Participating in other clinical trial during the present trial period 4. Acute febrile illness or acute infectious disease 5.History of a previous severe allergic reaction. 6. History of H1N1 Influenza infection or any influenza vaccination. 7. Positive serology for HIV antibody, HCV antibody or Hepatitis B surface antigen. 8.History of Guillain-Barré Syndrome. 9. Known history of a bleeding disorder

Investigators

Sponsor
Serum Institute of India Limited SII

Similar Trials